Who are Solaris Pharma's investors?

Solaris Pharma's investors include Salvia.

How much funding has Solaris Pharma raised?

Solaris Pharma has disclosed $23.4M raised across 2 of its 3 known rounds.

Where is Solaris Pharma headquartered?

Solaris Pharma is headquartered in Bridgewater, US.

Solaris Pharma

Bridgewater, US · Founded 2014 · 1 known investors

Solaris Pharma develops and supplies generic pharmaceutical formulations that are therapeutically equivalent to branded reference products, spanning multiple dosage forms and therapeutic categories. The company emphasizes regulatory compliance and quality assurance for essential medicines.

BiotechHealthtech

Founders & leadership

Srinivasan Lakshmi RaghavanExecutive

Investors · 1

SalviaHolzkirchen

Reported raises · per SEC filings

Form D private placements

$23.4M disclosed across 2 of 3 rounds · 2016–2019

▶$10MraisedJan 2020 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Bernhard HamplDirector
Srinivas Lakshmi RaghavanExecutive Officer, Director
Manish PottiDirector
Satish PejaverExecutive Officer, Director
Helmut JeggleDirector

Offering amount: $10M
Amount sold: $10M
First sale: Dec 2019
Incorporated: Corporation, New Jersey
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶Undisclosed amountofferedAug 2018 · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Srinivasan Lakshmi RaghavanDirector

Incorporated: Corporation, New Jersey, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$13.4MraisedNov 2016 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Srinivasan Lakshmi RaghavanExecutive Officer, Director

Offering amount: $13.4M
Amount sold: $13.4M
Minimum investment: $219K
Incorporated: Corporation, New Jersey, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Inven75 shared keywordsInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.

Companies competing with Solaris Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Solaris Pharma do?: Solaris Pharma develops and supplies generic pharmaceutical formulations that are therapeutically equivalent to branded reference products, spanning multiple dosage forms and therapeutic categories. The company emphasizes regulatory compliance and quality assurance for essential medicines.
Who are Solaris Pharma's investors?: Solaris Pharma's investors include Salvia.
How much funding has Solaris Pharma raised?: Solaris Pharma has disclosed $23.4M raised across 2 of its 3 known rounds.
Where is Solaris Pharma headquartered?: Solaris Pharma is headquartered in Bridgewater, US.